Global Medical Stock Price, News & Analysis

Global Medical REIT (NYSE: GMRE) reported robust financial results for 2021, with a 23.7% year-over-year revenue increase to $115.9 million. The company achieved a net income of $11.8 million, up from a loss of $7.7 million the previous year. Fourth quarter earnings showed net income of $3.8 million, or $0.06 per diluted share, alongside FFO of $0.23 per share. GMRE invested $196 million in medical real estate, including new acquisitions and expansions, with a weighted average cap rate of 7.6%. The company maintained a strong balance sheet with a leverage ratio of 43% and an unutilized borrowing capacity of $222.5 million.

Global Medical REIT Inc. (NYSE: GMRE) announced its plan to release fourth quarter and year-end 2021 financial results on February 28, 2022, after market close. A conference call will follow on March 1, 2022, at 9:00 a.m. ET, hosted by CEO Jeffrey Busch, CFO Robert Kiernan, and CIO Alfonzo Leon. Participants can access the call via webcast at the company’s investor section or by dialing in. The replay will be available from 12:00 p.m. ET on March 1 to midnight ET on March 15. More information can be found on their official website.

Global Medical REIT (NYSE: GMRE) has released its inaugural Corporate Social Responsibility Report, highlighting its commitment to environmental, social, and governance (ESG) initiatives. The report outlines the Company’s efforts since 2019 to track tenant energy and water usage, achieving a significant increase in participation from 11% to approximately 51%. Additionally, GMRE improved its GRESB assessment score from 21 in 2019 to 42 in 2020. The report emphasizes the Company’s sustainability vision based on alignment, access, and authenticity, showcasing programs to support community health and governance practices focused on integrity.

Global Medical REIT (NYSE: GMRE) announced that the federal income tax treatment of dividends paid in 2021 is now available on their website. Stockholders should review their Forms 1099 and other tax statements from their brokerage firms to ensure accuracy. Consulting with tax advisors regarding individual tax implications is recommended. The REIT focuses on owning and leasing healthcare facilities to reputable healthcare systems.

Global Medical REIT (NYSE: GMRE) has declared a fourth quarter cash dividend of $0.205 per share for common stock, to be paid on January 10, 2022 to shareholders on record as of December 27, 2021.

The company also announced a preferred dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, payable on January 31, 2022 to stockholders on record as of January 15, 2022.

Global Medical REIT (NYSE: GMRE) reported strong third quarter 2021 results with a net income of $3.7 million, or $0.06 per diluted share, recovering from a net loss of $(10.3) million in the previous year. Revenue surged by 19.5% to $30.0 million, driven by significant acquisitions totaling $163 million year-to-date. Funds from Operations (FFO) rose to $0.23 per share. The portfolio remains robust with 99% occupancy and favorable rent coverage of 4.6 times. Management plans further acquisitions, maintaining growth momentum.

Global Medical REIT Inc. (NYSE: GMRE) announced its plans to release third quarter 2021 financial results on November 3, 2021, after market close. A subsequent conference call will occur on November 4, 2021, at 9:00 a.m. Eastern Time. The call will be hosted by CEO Jeffrey Busch and his team. Investors can access the call via live webcast on the company's website. A replay will be available from 12:00 p.m. ET on November 4 until midnight ET on November 18.

Global Medical REIT (NYSE: GMRE) has declared its 2021 third quarter dividends. The common cash dividend is set at $0.205 per share, payable on October 8, 2021, to stockholders of record as of September 24, 2021. Additionally, a quarterly cash dividend of $0.46875 per share on its Series A Preferred Stock will be paid on November 1, 2021, for Series A Preferred shareholders of record as of October 15, 2021.

Global Medical REIT (NYSE: GMRE) reported strong financial results for Q2 2021, with net income of $2.6 million ($0.04 per diluted share), up from $0.2 million last year. Total revenue increased by 28.1% year-over-year to $28.3 million, driven by significant acquisition activity. Funds from Operations (FFO) rose to $0.22 per share, while Adjusted Funds from Operations (AFFO) reached $0.23 per share. The company completed seven acquisitions for $71 million, maintaining a 99% portfolio occupancy rate. GMRE also reduced leverage from 52% to 41% through equity offerings totaling $201 million.